Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biotage financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
KR161.8
2024-10-29
Market Capitalization
KR13.3 B
2024-10-29
Revenue
KR2.1 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 910.9M | 1.1B | 1.1B | 1.2B | 1.6B | 1.9B | 2.1B |
| Cost of goods sold | 349.4M | 406.7M | 418.4M | 466.0M | 605.0M | 700.0M | 754.0M |
| Gross profit | 563.2M | 695.0M | 675.1M | 767.0M | 963.0M | 1.2B | 1.4B |
| Gross profit margin, % | 61.8% | 63.1% | 61.8% | 62.3% | 61.5% | 62.5% | 66.6% |
| Operating expense total | 366.5M | 415.0M | 414.6M | 437.0M | 570.0M | 715.0M | 805.0M |
| Depreciation and amortization | 38.9M | 74.4M | 73.6M | 75.0M | 101.0M | 149.0M | 185.0M |
| EBITDA | 196.1M | 280.1M | 259.6M | 330.0M | 393.0M | 448.0M | 564.0M |
| EBITDA margin, % | 21.5% | 25.4% | 23.8% | 26.8% | 25.1% | 24.1% | 27.4% |
| EBIT | 157.2M | 205.7M | 186.0M | 255.0M | 292.0M | 299.0M | 379.0M |
| EBIT margin, % | 17.3% | 18.7% | 17.0% | 20.7% | 18.6% | 16.1% | 18.4% |
| Interest income | 630.0K | 765.0K | 348.0K | 2.0M | 9.0M | 12.0M | |
| Interest expense | 1.7M | 2.9M | 3.3M | 3.0M | 5.0M | 40.0M | 43.0M |
| Pre tax profit | 176.3M | 212.0M | 222.7M | 269.0M | 348.0M | 303.0M | 328.0M |
| Income tax expense | 8.7M | 25.2M | 47.4M | 64.0M | 80.0M | 57.0M | 44.0M |
| Net Income | 167.6M | 186.8M | 175.3M | 205.0M | 268.0M | 246.0M | 284.0M |